logo
Loading...
IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial

Medicine and Health

IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial

G. M. Chertow, A. M. Chang, et al.

This exciting study investigates clazakizumab, an IL-6 targeting antibody, finding that it significantly reduces inflammatory biomarkers in dialysis patients with cardiovascular disease and/or diabetes. Conducted by a team of experts, including Glenn M. Chertow and Yuliya Lokhnygina, this research showcases a remarkable 86-92% reduction in hs-CRP levels after treatment.... show more
Citation Metrics
Citations
69
Influential Citations
3
Reference Count
39
Citation by Year

Note: The citation metrics presented here have been sourced from Semantic Scholar and OpenAlex.

Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 22+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny